Table 1.
Centres for disease control and prevention staging of human immunodeficiency virus patients studied.
| CD4+ cell-based categories | Clinical categories |
Total | ||||||
|---|---|---|---|---|---|---|---|---|
|
A |
B |
C |
||||||
|
Asymptomatic acute HIV or PGL |
Symptomatic conditions,not A or C |
AIDS-indicator conditions |
||||||
| Cases studied | Cases with ocular lesions | Cases studied | Cases with ocular lesions | Cases studied | Cases with ocular lesions | Cases studied | Cases with ocular lesions | |
| 1. > 500 cells/μL | 35 | 7 | 0 | 0 | 1 | 0 | 36 | 7 |
| 2. 200-499 cells/μL | 126 | 19 | 4 | 0 | 23 | 7 | 153 | 26 |
| 3. < 200 cells/μL | 95 | 37 | 10 | 2 | 27 | 15 | 132 | 54 |
| Total | 256 | 63 | 14 | 2 | 51 | 22 | 321 | 87 |
CDC: centres for disease control and prevention; HIV: human immunodeficiency virus; AIDS: acquired immunodeficiency syndrome; PGL: persistent generalised lymphad-enopathy.